HIV Integrase Compound Synthesis with Protected Intermediates

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

There is a need for synthetic methods and intermediates to prepare novel compounds effective against HIV infection, particularly those targeting HIV integrase, as existing drugs face issues with toxicity and resistance.

Innovation Solution

A novel synthetic process is developed for preparing a compound of Formula I or its salts, involving specific reaction steps and intermediates, including the use of catalysts, deprotecting agents, and methylene reagents to form the desired compound.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If existing HIV drugs targeting reverse transcriptase and protease are used, then viral replication is inhibited, but toxicity and development of resistant strains occur

Engineering Contradiction:

Improveeffectiveness against HIVVSAvoidtoxicity and resistance

Core Design Contradiction:

ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent segments the HIV treatment approach by targeting a different enzyme (integrase) rather than using the same target (reverse transcriptase/protease), dividing the therapeutic strategy into distinct mechanistic pathways to avoid cross-resistance and reduce cumulative toxicity

Inventive Principle:

Principle #1Segmentation

Solution Approach 2:

The patent introduces integrase as an intermediary target in the viral replication pathway, which acts as a mediator between reverse transcriptase and the proviral DNA integration step, providing a new therapeutic entry point that bypasses resistance mechanisms developed against earlier targets

Inventive Principle:

Principle #24Intermediary (Mediator)

2Manufacturing precision

If multi-step synthetic processes are used to prepare complex antiviral compounds, then desired compounds are obtained, but manufacturing complexity and time increase

Engineering Contradiction:

Improvecompound synthesis accuracyVSAvoidsynthetic process complexity

Core Design Contradiction:

Manufacturing precisionVSDevice complexity

Solution Approach 1:

The patent merges multiple synthetic operations into a streamlined sequence by using protecting group strategies that allow consecutive reactions without intermediate purification steps, combining what would traditionally be separate synthetic campaigns into an integrated process

Inventive Principle:

Principle #5Merging (Combining)

Solution Approach 2:

The patent applies preliminary protection of functional groups (hydroxyl and amine) before subsequent reactions, allowing later steps to proceed without concern for unwanted side reactions, thereby simplifying the overall synthetic planning and reducing the need for protective measures during later stages

Inventive Principle:

Principle #10Preliminary action

Data Source

PatentUS20250296933A1Methods and intermediates for preparing therapeutic compounds

Publication Date: 2025.09.25 GILEAD SCIENCES INC

AI summary

The present disclosure relates to methods and intermediates useful for preparing a compound of Formula I:or a salt thereof.